DREAMA HARVEY: Open Payments
NPI 1306402383 · BLOOMINGTON, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$684 in 38 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $684
Food & beverage: $584Education: $100
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $268 |
| Janssen Biotech, Inc. | 2 | $129 |
| Amgen Inc. | 4 | $79 |
| UCB, Inc. | 3 | $64 |
| Novartis Pharmaceuticals Corporation | 3 | $60 |
| Braeburn Inc. | 2 | $31 |
| Lilly USA, LLC | 1 | $25 |
| Mallinckrodt Hospital Products Inc. | 1 | $14 |
| GlaxoSmithKline, LLC. | 1 | $13 |
Products named: SKYRIZI, TREMFYA, RINVOQ, Bimzelx, COSENTYX, ENBREL, BRIXADI, TALTZ.
Industry payments across IN — which companies pay providers there.
